Guest guest Posted January 15, 2008 Report Share Posted January 15, 2008 I wrote a letter to the New York Times editor on this one. Doubt they will ever publish it. Pfizer will make millions or billions on a drug that treats a symptom and which increases the hypo condition/symptoms, IMHO!! I just want to scream, scream, scream. http://www.nytimes.com/2008/01/14/health/14pain.html? _r=1 & scp=1 & sq=Drug+approved.+Is+disease+real%3F & oref=slogin " In many patients, Lyrica causes weight gain and edema, or swelling, as well as dizziness and sleepiness. In 12-week trials, 9 percent of patients saw their weight rise more than 7 percent, and the weight gain appeared to continue over time. The potential for weight gain is a special concern because many fibromyalgia patients are already overweight: the average fibromyalgia patient in the 2007 survey reported weighing 180 pounds and standing 5 feet 4 inches. " I'm 5-4-1/2 and I was 181 pounds before my last severe bout through 2004 that sent me to Dr. . Or how about this one: " Dr. Amy Chappell, a medical fellow at Lilly, said that even though Cymbalta is an antidepressant, its effects on fibromyalgia pain are independent of its antidepressant effects. In clinical trials, she said, even fibromyalgia patients who are not depressed report relief from their pain on Cymbalta. The overall efficacy of Cymbalta and milnacipran is similar to that of Lyrica. Analysts and the companies expect that the drugs will probably be used together. 'There's definitely room for several drugs,' Dr. Chappell said. " Slice it, dice it, never treat the root cause. Make billions upon billions. And go to war on Armour Thyroid and compounded meds. That's the ticket! Sara Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.